This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Medifast (MED) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Medifast (MED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want To Retire Early? Learn the Intelligent Investing Secret - October 28, 2019
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
How Trading Your Own Retirement Can Fleece Your Financial Future - October 25, 2019
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
Powerful Proof Anyone Can Invest for an Early Retirement - October 18, 2019
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
The Extreme Risks of Trading Your Own Retirement Assets - October 17, 2019
by Zacks Equity Research
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
Easy Investing Secrets to an Early Retirement - October 10, 2019
by Zacks Equity Research
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
The Extreme Risks of Trading Your Own Retirement Assets - October 09, 2019
by Zacks Equity Research
Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.
McCormick (MKC) Stock Up as Q3 Earnings & Sales Rise Y/Y
by Zacks Equity Research
McCormick & Company's (MKC) fiscal third-quarter performance reflects improved sales and margins. Management narrows its sales guidance range and raises guidance for the bottom line.
Conagra's (CAG) Q1 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Conagra's (CAG) top line grew year over year in first-quarter fiscal 2020, backed by gains from Pinnacle Foods, partly countered by divestiture of Sold Businesses.
Helen of Troy Gains on Leadership Brands: Will Momentum Stay?
by Zacks Equity Research
Helen of Troy's (HELE) focus on Leadership Brands, sturdy digital efforts and Transformation Plan bode well. However, elevated costs and soft Personal Care business are concerning.
4 Major Reasons Why Hershey is Set to Sustain Strong Momentum
by Zacks Equity Research
Hershey (HSY) regularly brings innovation to meet consumer demand. Further, the company is focusing on solidifying its footing in the growing snacking business.
5 Stocks to Ride Out Renewed U.S.-China Trade Tension
by Zacks Equity Research
Though the United States and China have renewed trade talks, the trade war is dampening economy and investors' sentiment. These five stocks can help you ride out the trade tension.
Zacks.com featured highlights include: NVR, MEDIFAST, BMC Stock, Universal Forest Products and EMCOR
by Zacks Equity Research
Zacks.com featured highlights include: NVR, MEDIFAST, BMC Stock, Universal Forest Products and EMCOR
5 DuPont-Tested Quality Stock Picks
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
Will Conagra's Focus on Innovation Continue to Fuel Stock?
by Zacks Equity Research
Conagra Brands (CAG) is launching a variety of on-trend items from several emerging and popular brands.
General Mills Q1 Earnings Preview: Will GIS Stock Continue Its Run?
by Christopher Vargas
General Mills (GIS) is set to report its first quarter earnings before the opening bell on Wednesday.
Newell Gains 24% in 3 Months on Solid Transformation Efforts
by Zacks Equity Research
Newell (NWL) progresses well with its Transformation Plan, which is likely to boost its operational performance and enhance shareholder value.
Sysco (SYY) Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Sysco (SYY) is benefiting from focus on its four core strategies, strong U.S. Foodservice unit, buyouts and cost-saving initiatives.
Will General Mills' (GIS) Q1 Earnings Gain From Pet Segment?
by Zacks Equity Research
General Mills' (GIS) Pet segment is likely to contribute to the top line in Q1. However, the North America Retail segment may remain pressurized.
Can Smucker's Buyouts & Saving Plans Aid Growth Amid Hurdles?
by Zacks Equity Research
Smucker's (SJM) buyouts, alliances and cost-saving efforts bode well. However, lower net price realization and effects of the U.S. baking business divestiture are concerns.
Flowers Foods (FLO) Stock Up 25% YTD: Will Momentum Stay?
by Zacks Equity Research
Flowers Foods (FLO) is benefiting from Project Centennial, impressive price/mix and focus on expansion through acquisitions. However, soft volumes and escalated costs are concerns.
Zacks.com featured highlights include: MEDIFAST, NVR, Universal Forest Products, EMCOR and AllianceBernstein
by Zacks Equity Research
Zacks.com featured highlights include: MEDIFAST, NVR, Universal Forest Products, EMCOR and AllianceBernstein
Helen of Troy Hits 52-Week High: Here Are the Factors at Play
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from strong Leadership Brands, robust online sales and core business advancements. The company is also on track with its transformation plan.
5 Top-Ranked Stocks Screened on DuPont Criteria
by Sanghamitra Saha
Have more faith in DuPont analysis than the simple ROE calculation and bet on these five stocks.
TreeHouse Foods Down 15% in 6 Months: Can Efforts Aid Revival?
by Zacks Equity Research
TreeHouse Foods (THS) is witnessing weakness in Baked and Meal Solutions units. Nevertheless, the company???s focus on its strategy for 2020 and Structure to Win program bode well.